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Abstract To further the functional annotation of the
mammalian genome, the Sanger Mouse Genetics Pro-
gramme aims to generate and characterise knockout mice
in a high-throughput manner. Annually, approximately 200
lines of knockout mice will be characterised using a
standardised battery of phenotyping tests covering key
disease indications ranging from obesity to sensory acuity.
From these ﬁndings secondary centres will select putative
mutants of interest for more in-depth, conﬁrmatory
experiments. Optimising experimental design and data
analysis is essential to maximise output using the resources
with greatest efﬁciency, thereby attaining our biological
objective of understanding the role of genes in normal
development and disease. This study uses the example of
the noninvasive blood pressure test to demonstrate how
statistical investigation is important for generating mean-
ingful, reliable results and assessing the design for the
deﬁned research objectives. The analysis adjusts for the
multiple-testing problem by applying the false discovery
rate, which controls the number of false calls within those
highlighted as signiﬁcant. A variance analysis ﬁnds that the
variation between mice dominates this assay. These vari-
ance measures were used to examine the interplay between
days, readings, and number of mice on power, the ability to
detect change. If an experiment is underpowered, we can-
not conclude whether failure to detect a biological differ-
ence arises from low power or lack of a distinct phenotype,
hence the mice are subjected to testing without gain.
Consequently, in conﬁrmatory studies, a power analysis
along with the 3Rs can provide justiﬁcation to increase the
number of mice used.
Introduction
The mouse is the model organism of choice for studying the
role of genes in normal development and disease, not least
because advances in genetic engineering have made the
genome highly tractable (Oliver et al. 2007; Zambrowicz
and Sands 2003). There is a coordinated, international effort
to produce (International Mouse Knockout Consortium
2007; Pettitt et al. 2009) and phenotype (Brown et al. 2006)
knockouts for all mouse genes and release the resulting
resource to the scientiﬁc community. Multiple phenotyping
centres are performing high-throughput, systematic, pri-
mary phenotypic screening of mutant mouse strains to
identify and highlight potential phenotypes of interest
associated with mutant strains (Brown et al. 2006; Justice
2008). Hypotheses can be developed from these data to
explain the role of the gene under investigation. The com-
plementary role of in-depth, follow-up phenotyping aims
to conﬁrm and extend the primary observations into
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associated with primary and secondary phenotyping are
therefore distinct. Within the primary centres there is a need
for high throughput, optimising the use of resources whilst
maximising sensitivity. In contrast, secondary centres need
to ensure sufﬁcient sensitivity is obtained to interrogate
conﬁdently the phenotype of interest. Different statistical
power is required to fulﬁl these distinct objectives.
Typically, differences are highlighted using univariate
statistical methods such as Student’s t test (Crawley 2005).
These tests calculate the probability (p) that the popula-
tions under comparison have the same mean and any dif-
ference arises from sampling variation. A change is
deemed signiﬁcant if the calculated p value falls below a
prescribed level, typically 0.05 (the ‘‘nominal signiﬁcance
level’’). Two types of error are possible: type I (a) and
type II (b). Type I represents a false-positive error which
occurs when a difference is declared to be signiﬁcant
erroneously. Type II represents a false-negative error
which occurs when the test fails to detect a true biological
difference. Power (1 - b) is the ability of a test to detect
change and it depends on the variance (noise), effect size
(magnitude of the treatment effect), number of replicates,
and nominal signiﬁcance that the researcher sets. To
increase the power for a given technique, the researcher
has most control over the number of replicates, but
increasing the number of replicates beyond a certain point
has little impact on the power. An undersized study will
not have the capacity to detect some changes as statisti-
cally signiﬁcant, whilst an oversized study will use more
resources than necessary. Typically, for primary, screening
experiments, a target power of 0.8 is used to ensure that
the majority of times a biological difference is detected,
whilst for secondary, conﬁrmation experiments, a power of
0.95 ensures that a difference is not missed if it exists
(Cohen 1988). Previously in the literature, power analyses
in animal experiments have focused on only simple
experimental designs (Festing 2003; Meyer et al. 2007),
and yet a review of toxicological experiments involving
animals suggests that a third of the experiments might be
unnecessarily large (Festing 1996).
The high-throughput nature of primary phenotyping
introduces the statistical problem of multiple testing, where
false positives accumulate. For example, at the 0.05 con-
ﬁdence level, 5% of sample differences will be statistically
signiﬁcant even though no biological difference exists. It
has been argued that in the context of exploratory experi-
ments, where conﬁrmatory investigations are performed,
allowing a low frequency of false leads would not present a
serious problem if the majority of signiﬁcant ﬁndings were
correctly chosen (Cui and Churchill 2003; Draghici 2002;
Qian and Huang 2005). This has led to the development of
methodologies to control the false discovery rate (FDR),
where the focus is on achieving an acceptable ratio of true
and false positives. These methods maintain sensitivity
whilst addressing the multiple-testing problem.
We have performed a case study to optimise experi-
mental design and ensure robust analysis using results from
noninvasive blood pressure (NIBP) testing. This method
uses an inﬂatable cuff secured at the base of the tail to
measure heart rate and blood pressure. Indirect methods,
such as this tail-cuff approach, have been recommended for
experimental studies with animals (Kurtz et al. 2005). The
protocol is automated and has been shown to give repro-
ducible results with conscious mice (Feng et al. 2008;
Krege et al. 1995) and to detect phenotypic differences in
models of cardiovascular disease (Cho et al. 2008; Roncon-
Albuquerque et al. 2008).
Raw NIBP data have a nested structure as measurements
are frequently taken multiple times within a day and can
also be taken across multiple days (Fig. 1) (Cho et al. 2008;
Feng et al. 2008; Krege et al. 1995; Roncon-Albuquerque
et al. 2008; Whitesall et al. 2004). These repeated measures
are not independent and this is an example of temporal
pseudoreplication where multiple time series measure-
ments are made that are of short duration such that no time-
dependent effects occur. Unless the statistical approach
considers this nesting, the correlation will lead to an
inﬂated estimate of statistical signiﬁcance and thus type I
errors (Hulbert 1984). Current users have addressed this by
using a standard Student’s t test on the mean of means (Cho
et al. 2008; Krege et al. 1995; Roncon-Albuquerque et al.
2008; Whitesall et al. 2004). An alternative approach is to
use a nested ANOVA, which models the covariance
structure introduced by the grouping of the data. With this
nested design, the effects of day and mouse are classed as
random effects because they inﬂuence only the variance,
not the overall mean, of the dependent variable. A major
beneﬁt of the nested design is that it economises on the
number of degrees of freedom used by the factor levels and
thus maintains power (Crawley 2005).
To ensure that robust results were obtained, the
assumptions underlying the three-level nested ANOVA
were investigated. In addition, the variance sources within
the assay were considered. With the ﬁndings, a statistical
power analysis assessing the sensitivity of the NIBP pro-
tocol was performed. The power analysis output directed
the experimental design to optimise throughput, minimis-
ing animal testing whilst retaining sufﬁcient power to
detect phenotypes of interest. Finally, the nested ANOVA
was applied to 46 mutant–control data sets for the three
parameters monitored. This comparison allowed us to
assess how the FDR can be used to address the risk of false
positives arising from the multiple-testing problem. There
are publications on various aspects of how experimental
design and statistical analysis are essential for experiments
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123in animal research (Festing 1994, 1996, 1997, 2003; Gaines
Das 2002; Kilkenny et al. 2009). This report provides a
comprehensive case study applied in an animal research
setting and pulls together all the individual components to
demonstrate how statistical techniques can help optimise
experimental design and ensure that ﬁndings are robust.
Materials and methods
Mice
The care and use of all mice in this study were in accor-
dance with UK Home Ofﬁce regulations, UK Animals
(Scientiﬁc Procedures) Act of 1986. Mice were created
from either the NIH-funded Knock Out Mouse Project
(KOMP) (Collins and Consortium 2007; Pettitt et al. 2009)
or the EU-funded European Conditional Mouse Mutagen-
esis program (EUCOMM) (Firebaugh and Gibbs 1985)
targeted ES cells by blastocyst injection (Pettitt et al. 2009)
or were generously donated to the Mouse Genetics Pro-
gramme by Wellcome Trust Sanger Institute Faculty
groups. Details of all lines of mice used in this study are
provided in Supplementary Data 1.
Mice were maintained in a speciﬁc pathogen-free unit
on a 12-h light:12-h dark cycle with lights off at 7:30 p.m.
and no twilight period. The ambient temperature was
21 ± 2C and the humidity was 60 ± 10%. Mice were
housed at a stocking density of 3–5 mice per cage [overall
dimensions of caging (L 9 W 9 H): 365 9 207 9 140 mm,
ﬂoor area = 530 cm
2] in individually ventilated cages
(Tecniplast Seal Safe1284L) receiving 60 air changes per
hour. In addition to Aspen bedding substrate, standard
environmental enrichment of two nestlets, a cardboard Fun
Tunnel, and three wooden chew blocks were provided.
Mice were given water and diet ad libitum. At 4 weeks of
age, mice were transferred from Mouse Breeders Diet (Lab
Diets 5021-3) to a high-fat (21.4% fat by crude content)
dietary challenge (Special Diet Services Western RD-
829100).
Blood pressure and heart rate analyses
The noninvasive blood pressure assay was performed on
approximately 11-week-old conscious mice using the
automated tail-cuff MC4000 Blood Pressure Analysis
System (Hatteras Instruments, Inc., Cary, NC, USA).
Equipment was calibrated weekly and pressure tests per-
formed daily following the manufacturer’s recommenda-
tion. To facilitate acclimatisation, thereby reducing stress
effects, mice were transferred to the measurement room at
least 1 day prior to the start of the procedure and remained
there for the entire data collection cycle. To address cir-
cadian variation, readings were collected between 08:30
and 12:30. To avoid introduction of bias, the experimenters
were blinded to the genotype during the procedure. Fur-
thermore, cages were processed randomly, and different
genotypes could be housed together, hence there was no
pattern to the order in which animals were processed. The
procedure was spread over 5 days, including one training
(thus these data were discarded) and four measurement
days, each consisting of 5 acclimatisation and 15 mea-
surement cycles. Within one measurement cycle, 70 con-
secutive waveforms were collected to provide a heart rate
measure, and then the tail cuff was inﬂated occluding blood
ﬂow to the tail. Systolic and diastolic blood pressures were
recorded as the pressure required to decrease the intensity
of the original waveform by 20 and 50%, respectively. For
each mutant–control comparison, we aimed for ten mice in
each study group; however, the number of mice did vary
between 5 and 23 for operational reasons. For example,
some lines were subviable so a full set of mice could not be
Fig. 1 The NIBP experiment
can have a three-level random-
effect nested design, where
readings from days are nested
within mice and the replicate
readings are nested within day.
The n represents the number of
readings taken in-house at each
level. Mice (m) are the level 3
unit, days (d) are the level 2
unit, and readings (r) are the
level 1 unit. The mutation
contrast is deﬁned at level 3
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123breed, or welfare-related issues arose during the NIBP
procedure resulting in the termination of the experiment.
Data analysis
Data analysis was completed using the freeware statistical
programR(IhakaandGentleman1996;http://www.r-project.
org/) unless otherwise stated. To estimate statistical power,
the freeware Optimal Design program was used (Rauden-
bush 1997; http://www.wtgrantfdn.org/resources/overview/
research_tools). To estimate q values, the freeware Q-value
program, which generates a graphical user interface with R,
was used (Storey 2002; http://genomics.princeton.edu/
storeylab/qvalue/).
Results
NIBP data capture
The data used for the following analysis were collected
from a total of 1086 mice as an integral part of the high-
throughput primary phenotyping programme ongoing at the
Sanger Institute. Each mouse was assessed using a stan-
dardized battery of phenotypic tests, including NIBP which
was performed over a 5-day period around 11 weeks of
age, as described above. Prior to NIBP, the mice were
exposed to a high-fat dietary challenge and weekly body
weight measurement (week 4 onwards), and had a simple
dysmorphology screen performed on them (week 9). Data
from a total of 23 unique alleles were split by gender
creating 46 unique mutant–control combinations (data
from mice heterozygous and homozygous for the targeted
allele were available for a subset of colonies) for analysis
(Supplementary data 1). The following analysis was com-
pleted on all the raw data and hence omits the user-review
stage (visual inspection of waveforms to ensure typical
structure is obtained), which is frequently used to try to
improve the data quality.
Selecting the appropriate statistical test
The selection of the statistical test depends on the research
objectives, the experimental design, and the data proper-
ties. The importance of considering these was highlighted
in 2009 when it was found that 60% of animal-based
research articles reviewed had issues with the transparency
and robustness of the statistical analysis (Kilkenny et al.
2009). The NIBP procedure is designed in such a way that
it gives data with a hierarchical structure. A three-level
random-effect nested ANOVA is a superior method of
statistical analysis for hierarchical data than the alternative
Student’s t test on the mean of means, both of which are
tests to identify differences in the variable mean (Crawley
2005). For knockout lines, where we have data for both
genders, we could use a two-way version of the above
techniques where the data are considered simultaneously.
This approach has the advantage of assessing whether a
statistically signiﬁcant interaction is occurring where the
effect of the genotype is not the same for the two genders.
When the interaction is not signiﬁcant, then a two-way
ANOVA would be more sensitive in detecting change than
an analysis that considers the genders independently.
Interpreting a two-way ANOVA can be tricky and is more
involved. In this article we have focused on a nested
ANOVA that considers genders independently as the
ﬁndings on this will be equally applicable to the two-way
nested ANOVA.
Like all statistical tests, a nested ANOVA has a number
of assumptions regarding the data under analysis. If these
assumptions are not met, the test becomes unreliable. A
nested ANOVA assumes that the observations within each
subgroup are (1) normally distributed, (2) have equal var-
iance, and (3) are independent. These assumptions were
tested on the raw data as described below.
Normality was assessed for 38 randomly selected groups
of readings, where a group comprises those measured from
a mouse for a day, with the Anderson–Darling test for
normality and a Q–Q normality plot. The data were found
to be unimodal. For systolic and diastolic blood pressure
data, the majority of groups of readings passed the test of
normality (76 and 75%, respectively), whilst for heart rate
data only 47% passed. The majority of failure arose from
outliers that were included in the data due to omission of
the user-review step which is frequently used to try and
improve the data quality.
To assess the equal variance assumption, residual
diagnostic plots were examined after ﬁtting a linear model
equivalent to a three-way nested ANOVA to mutant–con-
trol data sets (Supplementary data 2). Here, the residues
(the difference between the actual value and the value
predicted by the model) were plotted as a function of the
independent variable to assess whether any systematic
behaviour was present. The residues were found to be
random in their distribution and not dependent on the
signal strength of the independent variable. The presence of
outliers could be seen; however, these spanned the entire
signal strength range. Thus, the assumption of equal vari-
ance was met.
In assuming independence, we are, in effect, assuming
that across the time span of the measurements no signiﬁ-
cant time-dependent effect exists. To assess for a day
effect, wild-type C57BL/6NTac (Taconic Denmark) mice
were examined both individually and as a gender group.
Individually for each mouse, the mean readings were
plotted against day and no pattern with time was found
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wild-type mice was plotted with time (Supplementary data
4) and the readings between days compared with a two-
tailed paired Student’s t test. For both genders, no visual
pattern with time was apparent and no statistically signif-
icant effect was seen for the three parameters across the
4 days of measurement.
As an ANOVA approach is considered robust and can
tolerate departures from the normality assumption, our
ﬁndings support the use of a three-level nested ANOVA as
an appropriate tool for studying NIBP data.
Assessing the variance at each level
The variance at each level of the data (number of mice,
days, and readings) was estimated by examining 46
mutant–control comparison data sets (Table 1; Fig. 2;
Supplementary data 5). No statistically signiﬁcant differ-
ence was seen between the estimated variances for the two
genders when assessed with an independent or paired
Student’s t test (data not shown). For blood pressure
measurements, on average 69% of the variation lay
between mice, 30% of the variation lay between days, and
1% lay between readings for a given mouse on a given day.
For heart rate, a higher proportion of the variance lay
between mice (84%), suggesting that either the variation
between days was much lower or that the variation between
mice was higher. These data sets were prepared without
user ﬁltering, which is a common procedure (Whitesall
et al. 2004). Omitting this stage did increase the number of
outliers seen during the testing of normality; however, even
with these outliers, only 1–3% of the variation arose from
the readings taken within a day.
Power analysis for optimisation of experimental design
In a nested design, the variance and number of readings at
each level inﬂuence the statistical power, with the factors at
higher levels having more inﬂuence (Raudenbush 1997;
Raudenbush and Xiao-Feng 2001). Power was calculated
using the three-level-model module of the freeware pro-
gram Optimal Design (Raudenbush 1997; Raudenbush and
Xiao-Feng 2001) for a 0.95 conﬁdence. To allow com-
parison across the different parameters, which have dif-
ferent units, a standardised effect-size measure, Cohen’s d,
was used (Cohen 1988). Here the effect size of interest is
standardised for the variability in the data, hence a d of 1
means that the difference in the mean is equivalent to 1
standard deviation unit. These values can also be related to
percentage overlap between distributions where a Cohen’s
d of 0.8 is equivalent to 50% overlap and as d increases the
overlap decreases (Cohen 1988). For an effect size of
Table 1 Variability at each experimental level
Parameter Proportion of variance
Level 3—between mice Level 2—between days Level 1—between readings
Mean Standard
deviation
Mean Standard
deviation
Mean Standard
deviation
Diastolic BP 0.69 0.13 0.30 0.13 0.01 0.01
Systolic BP 0.69 0.14 0.30 0.14 0.01 0.01
Heart rate 0.84 0.09 0.13 0.07 0.03 0.02
BP blood pressure
The variability between clusters was estimated as a proportion of the variance at each level for 46 mutant–control comparison data sets for each
of the parameters studied in the NIBP procedure. The mean was calculated across all 46 comparisons and thus pools data from both genders and
from different genetic backgrounds
Fig. 2 Boxplot comparison showing the distribution of the variance
between mice, days, and readings for each of the three parameters
monitored in the NIBP procedure from the 46 mutant–control data set
comparisons. The whiskers extend to the most extreme data point,
which is no more than 1.5 times the interquartile range. Points beyond
this are classed as outliers and are shown as individual circles
N. A. Karp et al.: Optimising phenotyping experimental design 471
123interest, the statistical power can be calculated for various
designs to investigate the inﬂuence of altering the number
of mice, days, or readings. Our typical experiment would
result in a data set from 20 mice (ten per group) with
readings from four consecutive days and 15 readings per
day. Consequently, the effect of the number of readings,
number of days, and number of mice on power was ana-
lysed by altering each variable one at a time whilst keeping
all other aspects of the design constant (Fig. 3).
For all effect sizes studied, the power analysis found that
once one reading per day was obtained no further increase
in power was realised with additional readings (Fig. 3a, b).
This is unsurprising and arises because the variation
between readings is so low, and as a level 3 factor, it is
least inﬂuential on the power obtained. Increasing the
number of days gave rise to a more typical power curve,
where after an initial increase, further increases in the
number of days results in diminishing returns (Fig. 3c, d).
Changes in the number of mice was the most inﬂuential
parameter, which arose from variation in mice dominating
but also because number of mice is a level 1 factor (Fig. 3e,
f). With the design of four days of readings for ten mice per
genotype (Fig. 3a, b), a Cohen’s d of 0.91, where the dis-
tributions overlap by 48%, will reproducibly be detected
for the blood pressure measurements (power = 0.80),
whilst a Cohen’s d of 0.77 (54% overlap) will reproducibly
Fig. 3 Power curves to
examine the effect on blood
pressure (a, c, e) and heart rate
(b, d, f) of changing one aspect
of the experimental design at a
time [per day (a, b), number of
days (c, d), and number of mice
(e, f)] whilst keeping all other
aspects of the experimental
design constant. When they are
kept constant they default to 10
mice per group, 4 days of
readings, and 15 readings per
day. The power was calculated
for three Cohen’s d effect sizes
(0.8, 1.0, and 1.2)
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comparison, we can detect only larger effect sizes [Cohen’s
d of 1.20 (38% overlap) in the blood pressure parameters
and Cohen’s d of 1.00 (45% overlap)] for heart rate with
this experimental design if the target power is set at 0.95, as
required in conﬁrmatory experiments.
Mutant–control comparisons: identifying
statistically signiﬁcant change whilst addressing
the multiple-testing problem
In this study, 46 mutant and control data set comparisons
were completed for the three parameters monitored
(Supplementary data 6). Twenty-eight signiﬁcant ﬁndings
were identiﬁed from the resulting 138 statistical tests per-
formed. However, with a large number of statistical tests
such as this, false positives (type I errors) can accumulate
such that if no biological differences were present, then
seven false positives would be expected if p = 0.05 sig-
niﬁcance threshold was used. Storey’s q-value method
addresses the multiple-testing problem by allowing control
of the FDR, which is the proportion of false calls of those
classiﬁed as signiﬁcant (Storey 2002) (Table 2). Storey’s
method found that with a p value threshold of 0.05, the
FDR is estimated at 22%. This means that of the 28 sta-
tistically signiﬁcant ﬁndings, six are estimated to be false
discoveries. Alternatively, a p value threshold of 0.025
leads to an estimate of three false calls in 21 statistically
signiﬁcant ﬁnds, whilst a p value threshold of 0.005 iden-
tiﬁes seven as statistically signiﬁcant with no false posi-
tives predicted. These results demonstrate how allowing a
low number of false calls increases the sensitivity. For each
statistical test completed in this study, the p and q values
are reported and the relationship between p value and
q value is shown (Supplementary data 7).
Assessing biological signiﬁcance by calculating
effect-size measures
For the 28 statistically signiﬁcant ﬁndings (p\0.05), the
biological signiﬁcance of each difference was assessed by
calculating the associated effect size (Table 3). The pro-
portion of the total variance that is attributed to the geno-
type difference was calculated (g
2) and is equivalent to the
coefﬁcient of determination (r
2). It was related to Cohen’s
d using Eq. 1 (Rosnow and Rosenthal 1996). This allows
the ﬁndings to be related to the Cohen’s d effect-size
measure used in the power calculations. For reference, the
absolute difference in mean was calculated for these
putative biologically signiﬁcant changes in blood pressure
and heart rate.
d ¼ 2r=
p
1   r2  
ð1Þ
Discussion
This study provides an example of how statistical investi-
gation is essential to ensure that the experiments deliver
meaningful results. This research ﬁnds that the three-level
nested ANOVA is a statistically appropriate method to
apply to NIBP data when multiple readings are collected
for a mouse, as the assumptions are met. Use of appropriate
statistical tools is essential to ensure correct leads are
identiﬁed for future studies, with the false-positive rate
controlled to the level selected by the researcher. This
study also demonstrates how optimisation of the experi-
mental design is essential to achieve the research objectives
in question but also to reduce work (and therefore cost) and
enhance welfare (reﬁne). As these are signiﬁcant issues in
animal research, it is critical therefore to complete these
analyses before embarking on experiments, particularly in
a high-throughput scenario.
To optimise the design of the experiment, the variation
sources in the data were investigated and used in a power
analysis. For heart rate measurements in NIBP, the varia-
tion between mice dominated such that on average 83% of
the variation arose from variation between mice, 13%
between days, and 3% between readings for a mouse from
a given day. For blood pressure measurements, 69% of the
variation arose from variation between mice, 30% between
days, and only 1% between readings for a mouse from a
given day. These results arose from data sets where no user
review occurred. This suggests that there is little value to
the user review process, omission of which saves a con-
siderable amount of time. With so little variation arising
between readings, a power analysis conﬁrms that once one
reading is obtained there is little beneﬁt from additional
readings. The number of days was inﬂuential in the
Table 2 Estimated number of false discoveries for various p value
thresholds
p Value
threshold
q Value
threshold
Number tests
classiﬁed as
statistically
signiﬁcant
Estimated
number of
false
positives
0.05 0.219 28 6
0.025 0.147 21 3
0.01 0.078 13 1
0.005 0.062 7 0
The p value is a measure of signiﬁcance in terms of the false-positive
rate and focuses on the test in isolation. The q value is a measure in
terms of the false discovery rate across all the statistical tests within
one experimental family
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123sensitivity obtained, but most signiﬁcant was the number of
mice used in the analysis. With this information, the opti-
mal design, which balances the cost with the available
resources and experimental objective, can be chosen.
Speciﬁcally, the current design in our facility achieves the
target power of 0.8 to detect large changes (80% of a SD
unit), which we feel is an appropriate goal for primary-
screening, hypothesis-generating research. Therefore, we
do not need to alter the number of mice or days in the
current experimental design. However, the number of
readings per day (up to 15) is excessive, yielding little
added value, and can conﬁdently be reduced without loss of
power. We settled on ﬁve readings per day to allow for
missing values that can arise from mouse movement during
the procedure. This is a reﬁnement from a welfare per-
spective as it reduces the number of measurement cycles
and, hence, the experimental duration.
For both practical and ethical reasons there is a drive to
reduce the number of animals used in a study, as reiterated
by the mantra of the three Rs (Burch and Russell 1959). If
an experiment is underpowered, the ﬁndings are incon-
clusive and hence a power analysis, along with the three
Rs, can be used to justify an increase in the number of
mice. However, with an overpowered study, the additional
readings are not necessary and the number of mice should
be reduced.
Table 3 Effect-size measures for the mutant–control comparisons that were identiﬁed as statistically signiﬁcant (p\0.05) when assessed with a
three-level random-effect nested ANOVA
Allele Genotype
comparison
Gender Parameter p Value q Value g
2 Cohen’s d Difference in mean
(control–mutant)
[HR (bpm) or BP
(mmHg)]
Tpm1
tm1aWtsi HETvWT F Heart rate 0.0366 0.1881 0.211 1.03 33.1
Mta1
tm1aWtsi HETvWT F Heart rate 0.0021 0.0432 0.267 1.21 41.7
HETvWT M Heart rate 0.0328 0.1759 0.148 0.83 24.6
HETvWT F Diastolic BP 0.0178 0.1292 0.168 0.90 10.9
HOMvWT M Heart rate 0.0009 0.0278 0.322 1.38 51.6
HOMvWT F Heart rate 0.0035 0.0617 0.304 1.32 56.4
Akt2
tm1Wcs HOMvWT M Heart rate 0.025 0.1468 0.133 0.78 -5.1
HOMvWT F Diastolic BP 0.0193 0.1323 0.065 0.53 8.0
HOMvWT F Systolic BP 0.0223 0.1448 0.060 0.51 8.13
Herc3
tm1a(EUCOMM)Wtsi HOMvWT M Heart rate 0.025 0.1468 0.103 0.68 -39.5
HOMvWT F Heart rate 0.04 0.1955 0.097 0.65 -32.2
Epc1
tm1aWtsi HETvWT M Systolic BP 0.0114 0.0946 0.132 0.78 -21.1
HETvWT M Diastolic BP 0.0083 0.0788 0.142 0.81 -20.1
HETvWT M Heart rate 0.0051 0.0650 0.180 0.94 -46.5
HETvWT F Heart rate 0.0052 0.0650 0.164 0.89 -35.1
Baz1b
tm1a(KOMP)Wtsi HETvWT M Heart rate 0.0412 0.1955 0.040 0.41 -25.4
HETvWT F Heart rate 0.0235 0.1449 0.062 0.51 -28.6
Mysm1
tm1a(KOMP)Wtsi HETvWT M Systolic BP 0.0064 0.0658 0.111 0.71 -10.9
HETvWT M Diastolic BP 0.0054 0.0650 0.107 0.69 -10.5
Tmc1
dn HOMvHET F Heart rate 0.0007 0.0278 0.055 0.48 -40.1
Cadm1
tm1.2Brd HOMvWT F Heart rate 0.0003 0.0278 0.236 1.11 -49.1
Cdh23
v HOMvHET F Systolic BP 0.0498 0.2194 0.045 0.43 -7.4
HOMvHET F Heart rate 0.0013 0.0321 0.175 0.92 -127.2
Magi2
tm1Grnt HETvWT M Systolic BP 0.0115 0.0946 0.089 0.62 -10.2
HETvWT M Diastolic BP 0.0469 0.2143 0.048 0.45 -7.2
Mta3
tm1a(KOMP)Wtsi HOMvWT M Diastolic BP 0.0281 0.1576 0.024 0.32 35.7
HOMvWT F Heart rate 0.0127 0.0321 0.066 0.53 18.7
Brd7
tm1aWtsi HETvWT M Heart rate 0.0058 0.0650 0.050 0.46 16.1
BP blood pressure, HR heart rate
Within the genotype comparison column, WT indicates that mice were wild type for the gene of interest. HET and HOM indicate that mice were
heterozygous and homozygous, respectively, for the targeted allele
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123Across the 46 mutant–control comparisons, a number of
statistically signiﬁcant ﬁndings could be identiﬁed
depending on the signiﬁcant threshold (p value) used. The
lower the p value threshold used, the lower the risk of a
false positive, which is a particular issue with a multiple-
testing scenario. However, protecting against a false posi-
tive in this manner increases the risk of a false negative,
where biologically signiﬁcant differences are missed. To
address the multiple-testing problem but maintain sensi-
tivity, the FDR was estimated for various thresholds of
signiﬁcance. This data set demonstrates that allowing some
false calls increases sensitivity whilst giving a measure of
the associated risk.
The most robust hit was found for metastasis associated
1( Mta1). Homozygous null mice of both genders displayed
an increase in heart rate of approximately 50–60 bpm
(p\0.05). This increase was detected to a lesser degree
(20–40 bpm) in heterozygous mice of both genders
(p\0.05), indicating a gene-dosage effect. Mta1 is a
broadly expressed gene [(Simpson et al. 2001); in-house
observation from lacZ reporter gene study] known to be a
component of the Mi-2/nucleosome remodeling and his-
tone deacetylase (NuRD) complex and therefore plays a
key role in regulation of gene expression. There are no
prior publications linking Mta1 with cardiac function,
although an alternative transcript was detected in the heart
(Simpson et al. 2001).
This case study demonstrates the value of using statis-
tical analysis to direct experimental design, thus allowing
an informed decision to ensure that the three Rs are being
met. Additional statistical analysis with effect size and
false discovery measures can ensure that the ﬁndings are
robust and that future downstream work is efﬁcient. This is
essential for minimising the experiments whilst maximiz-
ing the potential beneﬁt to scientiﬁc knowledge.
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